In recent years, quinoline-based fibroblast activation protein (FAP) inhibitors (FAPI) have
shown promising results in the diagnosis of cancer and several other diseases, making them …

Simple Summary FAPI represents a novel class of radiotracers demonstrating promising
results in terms of a high uptake in concordance with low background noise in several …

Several recent studies comparing radiolabeled fibroblast activation protein inhibitors (FAPI)
and fluorine-18 fluorodeoxyglucose ([18F] F-FDG) as positron emission tomography (PET) …

Fibroblast activation protein (FAP), overexpressed on cancer-associated fibroblasts (CAF), is
a novel target for molecular imaging of various tumors. Recently, the development of several …

Objective To evaluate the potential value of [68Ga] Ga-labelled fibroblast activation protein
inhibitor ([68Ga] Ga-FAPI) positron emission tomography/computed tomography (PET/CT) in …

Background. Cancer‐associated fibroblasts (CAFs) can strongly modulate the response to
therapy of malignant tumor cells, facilitating their continuous proliferation and invading …

FAPI-based radiopharmaceuticals are a novel class of tracers, mainly used for PET imaging,
which have demonstrated several advantages over [18F] FDG, especially in the case of low …

Purpose This study was designed to compare the performance of 68Ga-FAPI-04 and 18F-
FDG PET/CT for initial staging and recurrence detection of head and neck squamous cell …

Simple Summary Several radiolabeled fibroblast activation protein targeted inhibitors (FAPI)
have been developed for molecular imaging and therapy. A potential correlation of …

Fibroblast-activation protein is a promising target for oncologic molecular imaging. Studies
show that fibroblast activation protein inhibitor (FAPI) radiotracers are accurate diagnostics …